Inspiring & original thinking. And, the latest news about us.
Welcome to Well Filtered™
A blog series dedicated to unearthing the ideas, perspectives, and innovations that matter most in kidney health.
- Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report 10.27.20
- RenalytixAI To Announce Financial Results for Full Year Ended June 30, 2020 and Provide Corporate Update 10.16.20
- RenalytixAI Receives California Commercial Laboratory Certification 09.22.20
- RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System 09.18.20
- RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX 08.26.20
- RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease 08.21.20
- KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients 08.03.20
- RenalytixAI Announces Over Allotment Option Exercise Raises an Additional US$10.9M 07.27.20
- RenalytixAI Announces Closing of Global Offering and Resulting Total Voting Rights 07.21.20
- RenalytixAI Announces Pricing of Global Offering and Approval to List on the Nasdaq Global Market 07.16.20